Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Axol Appoints New Scientific Advisory Board Member
Wednesday, April 20, 2016
Renowned neurodegenerative disease pioneer, Steve Finkbeiner joins the stem cell disease model specialists.

Promethera Acquires Cytonet Assets
Tuesday, April 19, 2016
Move creates global leader in regenerative medicine and cell therapy for liver diseases.

Mutated Mitochondria Found in Stem Cells
Friday, April 15, 2016
Researchers find hidden genetic mutations in patient-derived stem cells which could ultimately undermine therapeutic benefit.

“Secret Sauce” for Personalized, Functional Insulin-Producing Cells
Thursday, April 14, 2016
Researchers uncover molecular switch to make effective sugar-responsive, insulin-releasing cells in a dish, offering hope for diabetes therapy.

Cell and Gene Therapy Catapult, UCLB and Imperial Innovations Announce Positive Interim Review
Wednesday, April 13, 2016
The Cell and Gene Therapy Catapult alongside UCL Business PLC (UCLB) and Imperial Innovations, has announced a positive interim review in the phase I/II trial conducted by Catapult Therapy TCR using a T cell therapy to target acute myeloid leukaemia (AML).

“Secret Sauce” for Personalized, Functional Insulin-producing Cells
Wednesday, April 13, 2016
Researchers uncover molecular switch to make effective sugar-responsive, insulin-releasing cells in a dish, offering hope for diabetes therapy.

Beta Cells from Love Handles
Tuesday, April 12, 2016
Using a synthetic genetic program to instruct stem cells taken from fatty tissue to become cells that are almost identical to natural beta cells, researchers are closer to creating a repair kit for diabetes patients.

Insights into Early Human Embryo Development
Monday, April 11, 2016
Researchers at Karolinska Institutet and the Ludwig Cancer Research in Stockholm have conducted a detailed molecular analysis of the embryo’s first week of development.

4D Pharma Acquires Instituto Biomar
Monday, April 11, 2016
4D pharma is pleased to announce that it has acquired the production assets of Instituto Biomar, S.A. ("Biomar"), a Spanish based contract research organisation specialising in microbial fermentation.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 2647
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!